Gemmer Asset Management’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-112
| Closed | -$3K | – | 1285 |
|
|
2017
Q3 | $3K | Hold |
112
| – | – | ﹤0.01% | 1182 |
|
|
2017
Q2 | $3K | Hold |
112
| – | – | ﹤0.01% | 1171 |
|
|
2017
Q1 | $3K | Buy |
112
+7
| +7% | +$173 | ﹤0.01% | 1159 |
|
|
2016
Q4 | $3K | Buy |
105
+16
| +18% | +$404 | ﹤0.01% | 1134 |
|
|
2016
Q3 | $2K | Sell |
89
-34
| -28% | -$872 | ﹤0.01% | 1192 |
|
|
2016
Q2 | $3K | Buy |
123
+39
| +46% | +$968 | ﹤0.01% | 1129 |
|
|
2016
Q1 | $1K | Hold |
84
| – | – | ﹤0.01% | 1218 |
|
|
2015
Q4 | $3K | Hold |
84
| – | – | ﹤0.01% | 1059 |
|
|
2015
Q3 | $2K | Hold |
84
| – | – | ﹤0.01% | 1171 |
|
|
2015
Q2 | $3K | Hold |
84
| – | – | ﹤0.01% | 1083 |
|
|
2015
Q1 | $2K | Hold |
84
| – | – | ﹤0.01% | 1250 |
|
|
2014
Q4 | $2K | Hold |
84
| – | – | ﹤0.01% | 1211 |
|
|
2014
Q3 | $2K | Hold |
84
| – | – | ﹤0.01% | 1210 |
|
|
2014
Q2 | $2K | Hold |
84
| – | – | ﹤0.01% | 1239 |
|
|
2014
Q1 | $2K | Buy |
+84
| New | +$2.06K | ﹤0.01% | 1222 |
|
Gemmer Asset Management's PMC Position: Q4 2017 in Review
Gemmer Asset Management sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 112 shares — an estimated $3K sold.
Gemmer Asset Management first reported a position in PMC in Q1 2014 and held it in 15 quarters. The position peaked at $3K in Q3 2017. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- Gemmer Asset Management reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- Gemmer Asset Management sold 112 PharMerica Corporation shares in Q4 2017, an estimated $3K.
- Gemmer Asset Management first reported a position in PharMerica Corporation in Q1 2014 and held it in 15 quarters.
- Gemmer Asset Management's PharMerica Corporation position peaked at $3K in Q3 2017.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on Gemmer Asset Management's 13F filing for Q4 2017, filed 16 Jan 2018.